Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Application of I-123 HIPDM as a lung imaging agent

Abstract

N,N,N′-Trimethyl-N′-(2-Hydroxyl-3-Methyl-5-123I Iodobenzyl)-1,3-Propanediamine · Hcl (123I-HIPDM) has been used for diagnosis of patients with strokes and dementias. Since this radiopharmaceutical is also accumulated in the lung, we routinely performed a lung image or images immediately prior to cerebral planar and SPECT images after a 3–5 mCi 123I-HIPDM injection. During the past 14 months, we obtained 78 (age from 41 to 92 years, average 66.7±8.9 years; 64 males, 14 females) suspected stroke or dementia patients' lung images. All lung images were correlated to chest X-ray (CXR) or CT and other clinical data. Sixty five of 78 patients had normal lungs showing homogeneous distribution of activity throughout the lungs which correlated well to normal CXR and/or CT studies. Abnormal scintigraphic patterns of the 13 patients included lung defect (5 bronchogenic carcinoma with or without atelectasis) and decreased uptake in apices (8 chronic obstructive pulmonary disease). The findings of pulmonary intrathoracic pathologies on lung images with 123I-HIPDM suggests further evaluation of the agent for detection of localized pulmonary diseases and pulmonary physiological studies relating to amine metabolism.

This is a preview of subscription content, log in to check access.

References

  1. Bend JR, Serabjit-Singh CJ, Philpot RM (1985) The pulmonary uptake, accumulation and metabolism of xenobiotics. Ann Rev Pharmacol Toxicol 25:97–125

  2. Brott TG, Gelfand MJ, Williams CC, Spilker JA, Hertzberg VS (1986) Frequency and patterns of abnormality detected by Iodine-123 amine emission CT after cerebral infarction. Radiology 158:729–734

  3. Gills CN, Pitt BR (1982) The fate of circularing amines within the pulmonary circulation. Ann Rev Physiol 44:269–281

  4. Gills CN (1986) Pharmacological aspects of metabolic processes in the pulmonary microcirculation. Ann Rev Pharmacol Toxicol 26:183–200

  5. Holman BL, Hill TC, Polak JF, Lee RGL, Royal HD, O'Leary DH (1984) Cerebral perfusion imaging with Iodine-123 labeled amines. Arch Neurol 41:1060–1063

  6. Kung HF, Tramposch K, Blau M (1983) A new brain perfusion imaging agent: I-123 HIPDM. J Nucl Med 24:66–72

  7. Pistolesi M, Fazio F, Marini G, Gerundini P, Gilardi MC, Colombo F, Miniati M, Taddei G, Fazzi P, Giuntini C (1983a) Lung distribution and kinetics of I-123 HIPDM: A potential agent for early detection of lung cellular injury (Abstract). J Nucl Med 24:P71

  8. Pistolesi M, Fazio F, Marini G, Gerundini P, Gilardi MC, Colombo F, Miniati M, Taddei G, Fazzi P, Giuntini C (1983b) Lung uptake of I-123 HIPDM in man: An index of lung metabolic function. J Nucl Med All Sci 27:180

  9. Pistolesi M, Miniati M, Ghelarducci L, Mazzuca N, Giuntini C, Taccini E, Renzoni G, Pellegrini N, Gilardi MC, Gerundini P, Fazio F (1985) Lung release of HIPDM: A new index of lung dysfunction for clinical and experimental studies (Abstract). J Nucl Med 26:P14

  10. Rahimian J, Glass EC, Touya JJ, Akber F, Graham LS, Bennett LR (1984) Measurement of metabolic extraction of tracers in the lung using a multiple indicator dilution technique. J Nucl Med 25:31–37

  11. Sullivan DC (1983) Radionuclide studies in lung disease. Semin Respir Med 5:31–42

  12. Touya JJ, Rahimian J, Grubbs DE, Corbus HF, Bennett LR (1985) A noninvasive procedure for in vivo assay of a lung amine endothelial receptor. J Nucl Med 26:1302–1307

Download references

Author information

Correspondence to Wei-Jen Shih.

Additional information

This investigation was supported in part by Biomedical Research Support Grant no. RR05374 from the Biomedical Research Support Branch, Division of Research Facilities and Resources, NIH

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Shih, W., Coupal, J.J., Dillon, M.L. et al. Application of I-123 HIPDM as a lung imaging agent. Eur J Nucl Med 14, 21–24 (1988). https://doi.org/10.1007/BF00252612

Download citation

Key words

  • 123I-HIPDM
  • Lung imaging agent
  • Capillary endothelial receptor
  • COPD
  • Bronchogenic carcinoma